Allergy transfer upon solid
organ transplantation has been reported in the literature, although only few data are available as to the frequency, significance, and management of these cases. Based on a review of 577 consecutive deceased donors from the Swisstransplant Donor-Registry, 3 cases (0.5%) of fatal
anaphylaxis were identified, 2 because of peanut and 1 of wasp
allergy. The sera of all 3 donors and their 10 paired recipients, prospectively collected before and after
transplantation for the Swiss Transplant Cohort Study, were retrospectively processed using a commercial
protein microarray fluorescent test. As early as 5 days posttransplantation, newly acquired peanut-specific
IgE were transiently detected from 1 donor to 3 recipients, of whom 1 liver and lung recipients developed grade III
anaphylaxis. Yet, to define how
allergy testing should be performed in transplant recipients and to better understand the impact of immunosuppressive therapy on
IgE sensitization, we prospectively studied 5 atopic living-donor kidney recipients. All pollen-specific
IgE and >90% of skin prick tests remained positive 7 days and 3 months after
transplantation, indicating that early diagnosis of donor-derived
IgE sensitization is possible. Importantly, we propose recommendations with respect to safety for recipients undergoing solid-
organ transplantation from donors with a history of fatal
anaphylaxis.